Author: Beam Therapeutics

Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference

May 13, 2026
Beam Therapeutics to Present Updated Biomarker Data from Phase 1/2 BEACON Trial Further Underscoring Risto-cel’s Ability to Restore Red Blood Cell Health and Function in Sickle Cell Disease at EHA2026

May 12, 2026

1 2

Beam Therapeutics to Present at 2026 RBC Capital Markets Global Healthcare Conference